The Magazine for Sleep Professionals
Saturday, April 18, 2026
Acquisitions | Awards | Events | News | Partnerships
ProSomnus Sleep Technologies announced its inclusion on the prestigious Inc. 5000 list of fastest growing private companies in the USA. This is the fourth year that ProSomnus has earned a spot on the Inc. 5000 list. Persistent and robust organic demand for ProSomnus’s sleep apnea devices, as opposed to price […]
Nox Medical has announced the U.S. launch of the Nox SAS™ solution: an advanced EEG technology that enables simplified, clinically rigorous PSG testing in any setting. Designed for use with the Nox A1® PSG recorder, the Nox SAS solution eliminates the complexity of traditional PSG setups while maintaining clinical-grade signal […]
Persante Healthcare has announced a strategic initiative to streamline efficiencies, improve communication, and position the company for scalable growth. As part of this initiative, Persante proudly welcomes Whitney Brenke as its newly appointed Chief Operating Officer (COO). Brenke brings over 15 years of executive leadership in healthcare operations, with a […]
Nyxoah SA announced that the U.S. Food and Drug Administration (FDA) has approved the Genio system (hypoglossal nerve stimulation) for a subset of patients with moderate to severe OSA with an Apnea-Hypopnea Index (AHI) of greater than or equal to 15 and less than or equal to 65. Genio is […]
Dormotech, a leader in advancing sleep diagnostics through innovative, clinically validated solutions, emphasized the urgent need for early and accessible diagnosis of sleep disorders in children. This critical focus echoes the profound insights shared by globally respected pediatric sleep medicine expert, Dr. Asher Tal. In an in-depth interview with Dormotech, […]
EnsoData, an innovator in AI healthtech solutions, announced a $20 million Series B financing led by Questa Capital. This new capital will enable EnsoData to accelerate adoption of its AI-powered sleep medicine solutions, improving the sleep care pathway for, in the US alone, an estimated 54 million patients suffering from […]
Today marks a transformative moment in the 35-year history of the American Sleep Apnea Association (ASAA). The organization proudly rebrands as the Wellness, Sleep & Circadian Network (WSCN), a global “KNOWLEDGE HUB” empowering anyone, anywhere to own all 24 hours with practical, science-based tools that improve sleep, circadian health, and overall well-being. […]
Nox Medical, a global leader in sleep diagnostic solutions, is proud to unveil the expanded capabilities of Nox Connect™, a secure, cloud-based platform that now features Artificial Intelligence, web-based scoring and interpretation, and a fully integrated Home Sleep Testing Service. The new platform features will be showcased at the SLEEP […]
Avadel Pharmaceuticals plc, a biopharmaceutical company focused on transforming medicines to transform lives, today announced that new data supporting the use of LUMRYZ as a narcolepsy treatment and additional data to better understand the real-life experience of people living with narcolepsy will be presented in four oral presentations and 14 […]
Axsome Therapeutics, Inc. a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it has entered into a settlement agreement with Hetero Labs Ltd. and certain of its affiliates (Hetero) resolving patent litigation related to Axsome’s product SUNOSI® (solriamfetol). The litigation, which […]
